Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery.

ABSTRACT: New biological tools provide new techniques to probe fundamental biological processes. Here we describe the burgeoning field of proteolysis-targeting chimeras (PROTACs), which are capable of modulating protein concentrations at a post-translational level by co-opting the ubiquitin-proteasome system. We describe the PROTAC technology and its application to drug discovery and provide examples where PROTACs have enabled novel biological insights. Furthermore, we provide a workflow for PROTAC development and use and discuss the benefits and issues associated with PROTACs. Finally, we compare PROTAC-mediated protein-level modulation with other technologies, such as RNAi and genome editing.

SUBMITTER: Burslem GM 

PROVIDER: S-EPMC7319047 | biostudies-literature |

REPOSITORIES: biostudies-literature